CORONARY DRUG ELUTING STENTS

Description :SRPHC82281215-CORONARY DRUG ELUTING STENTS (1) WITH SINGLE WIRE DESIGN WI TH COBALT ALLOY SHELL AND PLATINUM IRIDIUM CORE (2) STENT WITH COATING OF BIOLINX POLYME R CARRIER FOR ACTIVE DRUG ZOTAROLIMUS SHOWN TO BE EFFECTIVE IN PREVENTING NEO-INTIMAL HYPERPLASIA (3) STENT DIAMETER SHOULD BE FROM 2 MM TO 5MM AND LENGTH OF THE STENT FRO M 8 MM TO 38 MM. (4) THE STRUT SHOULD BE ROUND WITH THICKNESS RANGING FROM 81 TO 91 MI CRONS (5) STENT DELIVERY SYSTEM SHOULD BE MONORAIL (SINGLE OPERATOR EXCHANGE OR RAPID EXCHANGE). (6) STENT SHOULD BE COMPATIBLE WITH 5FR GUIDING CATHETER (7) STENT DESIGN SH OULD BE OPEN CELL TYPE. (8) STENT SHOULD BE APPROVED BY DCGI. THE COPY OF DCGI APPROVAL SHOULD BE ENCLOSED IN THE TENDER BID. (9) FIVE YEARS EFFICACY AND SAFETY OF THE STENT IN T ERMS OF TARGET VESSEL REVASCULARISATION (TVR) AND IN-SITU THROMBOSIS (IST) SHOULD BE DO CUMENTED / PUBLISHED IN PEER REVIEWED SCIENTIFIC JOURNALS.(10) THE DOCUMENTS PERTAINING TO THE EFFICACY AND SAFETY OF THE STENT SHOULD BE ENCLOSED FOR THE BRAND THAT IS OFFER ED IN THE TENDER BID (11) THE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF TH E STENT TO A MAJOR GOVERNMENT INSTITUTE. ] Consignee ACHD/Surg.Store/RH/PER, SR Tamil Nadu 12.00 Numbers